As usually happens in patients with mutations in the SLCO2A1 gene, this patient suffered from pachydermoperiostosis (PDP), but no cognitive/neurological clinical manifestations were identified [142]. The gene discussed is SLCO2A1; the disease is Pachydermoperiostosis.